Biosimilars: A Fancy Name for Generics But Oh So Much More Disastrous

Sep 07, 2007

Over on VentureBeat, David Hamilton writes that even normally smart biotechnology investors get a little dim when talking about biosimilars and the loss of patent protection for biotech drugs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Now Some New Council Members

Seven individuals have been named to the President's Council of Advisors on Science and Technology, ScienceInsider reports.

From Tweets to Concern and Disagreement

Retraction Watch reports that a series of tweets led to expression of concern for a PLOS Genetics paper, a move the paper's authors disagree with.

Puma Genetic Diversity Struggles

Researchers have sequenced pumas from North and South America to enable better identification of inbreeding, Cosmos magazine reports.

Nucleic Acids Research Studies Describe Cell Viability Signature, Han Chinese Genome Database, More

In Nucleic Acids Research this week: ways to find cell death or proliferation signatures, Han Chinese population genome database, and more.

Menu